Category: Workers Comp

552 posts found

Medmonitor

CMS Drug Pricing Negotiation to Lower Costs of 15 Drugs

The 2025 negotiations covered drugs for obesity, cancer, diabetes, COPD, asthma, and more.

This Month's Must Read

The Injured Worker: An Essential, Sometimes Overlooked Partner in Improving Pharmacy Network Utilization

Engaging directly with injured workers is one important way to improve pharmacy network utilization in workers’ comp.

Marijuana Updates

JAMA Publishes New Review for Therapeutic Use of Cannabis

The review examines the efficacy of cannabis therapy for various indications, including chronic pain and psychiatric conditions.

Industry Trends

Minnesota Reports on Prescription Drug Price Transparency

Drug classes with the most new, high-priced drugs were anti-cancer drugs, ADHD/anti-obesity drugs, and anti-inflammatory pain medications.

Legislation & Policy

New York Could Remove References to CDC Guidelines

After regional public health collaboratives formed in September, New York could be the first state to formally shift policies away from deferring to federal guidelines.

Medmonitor

White House Announces Deal to Expand Access to GLP-1 Medications

Qualifying CMS patients could pay as little as $50 a month for Ozempic or Wegovy.

This Month's Must Read

Common Exceptions: The Rising Incidence of Complex Claims in Workers’ Compensation

Understanding the factors that drive longer claim duration and higher costs.

Legislation & Policy

California to Expedite Research Around Schedule I & II Drugs

Assembly Bill 1103 was enacted, allowing for the Research Advisory Panel to expedite the review and approval of research applications.

Workforce Trends

NCCI Reports on Remote Work and Workers’ Comp Frequency

According to the NCCI, remote work makes up 20–30% of the U.S. workforce, up from 4–7% pre-pandemic.

Clinical Insights

JAMA Study Notes Possible Cardiovascular Benefits for GLP-1 Antagonists

Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.

Healthe Developments

Healthe Leaders Share Insights

CEO Daryl Corr and SVP Todd Piscoitti were featured in WorkCompWire’s Leaders Speak series, while VP of Clinical Services, Silvia Sacalis’ recaps her National Comp presentation.

Medmonitor

New Osteoporosis Biosimilar Approved

Enoby™ (denosumab-qdbe) injections are a biosimilar of Prolia^®, to help increase bone mass in those with high risk of fracture.

This Month's Must Read

The Injured Worker Patient in 3D: Driving More Personalized Care Through Strategic Formulary Design

With an effective formulary strategy, PBMs can ensure injured worker patients receive the most appropriate care and create better outcomes.

Clinical Insights

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.

Legislation & Policy

NCCI Publishes 2025 Regulatory and Legislative Trends Report

NCCI tracked 950 bills impacting workers’ comp, highlighting key trends across the country, such as PTSD and cancer presumptions, worker classification, and psychedelics.

1 2 3 4 5 … 33 34 35 36 37 Next